Stenotrophomonas maltophilia strains replicate andpersist in the murine lung, but to significantly different degrees

Microbiology

Volumn 157, Issue 7, 2011, Pages 2133-2142

  Rouf, Ruella ^a   Karaba, Sara M ^a   Dao, Jenny ^a   Cianciotto, Nicholas P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; FEMALE; INOCULATION; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

ANIMALS; CYTOKINES; GRAM-NEGATIVE BACTERIAL INFECTIONS; LUNG; MICE; MICE, INBRED A; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; STENOTROPHOMONAS MALTOPHILIA; VIRULENCE FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA; MURINAE; MUS; STENOTROPHOMONAS; STENOTROPHOMONAS MALTOPHILIA;

EID: 79959975616     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.048157-0     Document Type: Article

References (54)

1. Ahn, S. H., Deshmukh, H., Johnson, N., Cowell, L. G., Rude, T. H., Scott, W. K., Nelson, C. L., Zaas, A. K., Marchuk, D. A. & other authors (2010). Two genes on A/J chromosome 18 are associated with susceptibility to Staphylococcus aureus infection by combined microarray and QTL analyses. PLoS Pathog 6, e1001088.
2. Alonso, A. & Martinez, J. L. (2000). Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44, 3079-3086.
3. Ansari, S. R., Hanna, H., Hachem, R., Jiang, Y., Rolston, K. & Raad, I. (2007). Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 109, 2615-2622.
4. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A. & Struhl, K. (1989). Current Protocols in Molecular Biology. New York: Wiley.
5. Avison, M. B., von Heldreich, C. J., Higgins, C. S., Bennett, P. M. & Walsh, T. R. (2000). A TEM-2 b-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother 46, 879- 884.
6. Avison, M. B., Higgins, C. S., Ford, P. J., von Heldreich, C. J., Walsh, T. R. & Bennett, P. M. (2002). Differential regulation of L1 and L2 blactamase expression in Stenotrophomonas maltophilia. J Antimicrob Chemother 49, 387-389.
7. Brieland, J., Freeman, P., Kunkel, R., Chrisp, C., Hurley, M., Fantone, J. & Engleberg, C. (1994). Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease. Am J Pathol 145, 1537-1546.
8. Crossman, L. C., Gould, V. C., Dow, J. M., Vernikos, G. S., Okazaki, A., Sebaihia, M., Saunders, D., Arrowsmith, C., Carver, T. & other authors (2008). The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9, R74.
9. Davies, J. C. & Rubin, B. K. (2007). Emerging and unusual Gramnegative infections in cystic fibrosis. Semin Respir Crit Care Med 28, 312-321.
10. DebRoy, S., Dao, J., Söderberg, M., Rossier, O. & Cianciotto, N. P. (2006). Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung. Proc Natl Acad Sci U S A 103, 19146-19151.
11. Denton, M. & Kerr, K. G. (1998). Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11, 57-80.
12. Di Bonaventura, G., Prosseda, G., Del Chierico, F., Cannavacciuolo, S., Cipriani, P., Petrucca, A., Superti, F., Ammendolia, M.G., Concato, C. & other authors (2007). Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol 20, 529-537.
13. Di Bonaventura, G., Pompilio, A., Zappacosta, R., Petrucci, F., Fiscarelli, E., Rossi, C. & Piccolomini, R. (2010). Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. Infect Immun 78, 2466-2476.
14. Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K. & Dimopoulos, G. (2009). Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur J Clin Microbiol Infect Dis 28, 719-730.
15. Figueirêdo, P. M., Furumura, M. T., Santos, A. M., Sousa, A. C., Kota, D. J., Levy, C. E. & Yano, T. (2006). Cytotoxic activity of clinical Stenotrophomonas maltophilia. Lett Appl Microbiol 43, 443-449.
16. Fouhy, Y., Scanlon, K., Schouest, K., Spillane, C., Crossman, L., Avison, M. B., Ryan, R. P. & Dow, J. M. (2007). Diffusible signal factordependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J Bacteriol 189, 4964-4968.
17. George, S. E., Kohan, M. J., Gilmour, M. I., Taylor, M. S., Brooks, H. G., Creason, J. P. & Claxton, L. D. (1993). Pulmonary clearance and inflammatory response in C3H/HeJ mice after intranasal exposure to Pseudomonas spp. Appl Environ Microbiol 59, 3585-3591.
18. Glomski, I. J., Dumetz, F., Jouvion, G., Huerre, M. R., Mock, M. & Goossens, P. L. (2008). Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting. Microbes Infect 10, 1398-1404.
19. Gordon, N. C. & Wareham, D. W. (2010). Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 65, 483-489.
20. Gould, V. C. & Avison, M. B. (2006). SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships. J Antimicrob Chemother 57, 1070-1076.
21. Hernandez, A., Mate, M. J., Sa nchez-Diaz, P. C., Romero, A., Rojo, F. &Martinez, J. L. (2009). Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. J Biol Chem 284, 14428-14438.
22. Huang, T. P. & Wong, A. C. (2007). A cyclic AMP receptor proteinregulated cell-cell communication system mediates expression of a FecA homologue in Stenotrophomonas maltophilia. Appl Environ Microbiol 73, 5034-5040.
23. Huang, Y. W., Lin, C. W., Hu, R. M., Lin, Y. T., Chung, T. C. & Yang, T. C. (2010). AmpN-AmpG operon is essential for expression of L1 and L2 b-lactamases in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 54, 2583-2589.
24. Kim, H. B., Srinivasan, S., Sathiyaraj, G., Quan, L. H., Kim, S. H., Bui, T. P., Liang, Z. Q., Kim, Y. J. & Yang, D. C. (2010). Stenotrophomonas ginsengisoli sp. nov., isolated from a ginseng field. Int J Syst Evol Microbiol 60, 1522-1526.
25. Lambiase, A., Raia, V., Del Pezzo, M., Sepe, A., Carnovale, V. & Rossano, F. (2006). Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis 6, 4-10.
26. Lee, M., Woo, S. G., Chae, M., Shin, M. C., Jung, H. M. & Ten, L. N. (2011). Stenotrophomonas daejeonensis sp. nov., isolated from sewage. Int J Syst Evol Microbiol 61, 598-604.
27. Looney, W. J., Narita, M. & Mü hlemann, K. (2009). Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9, 312-323.
28. McKay, G. A., Woods, D. E., MacDonald, K. L. & Poole, K. (2003). Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun 71, 3068-3075.
29. Minkwitz, A. & Berg, G. (2001). Comparison of antifungal activities and 16S ribosomal DNA sequences of clinical and environmental isolates of Stenotrophomonas maltophilia. J Clin Microbiol 39, 139- 145.
30. Nicoletti, M., Iacobino, A., Prosseda, G., Fiscarelli, E., Zarrilli, R., De Carolis, E., Petrucca, A., Nencioni, L., Colonna, B. & Casalino, M. (2011). Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol 301, 34-43.
31. Okazaki, A. & Avison, M. B. (2007). Aph(39)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 51, 359-360.
32. Paez, J. I., Tengan, F. M., Barone, A. A., Levin, A. S. & Costa, S. F. (2008). Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis 27, 901-906.
33. Paschoal, I. A., de Oliveira Villalba, W., Bertuzzo, C. S., Cerqueira, E. M. & Pereira, M. C. (2007). Cystic fibrosis in adults. Lung 185, 81-87.
34. Qiu, H., KuoLee, R., Harris, G. & Chen, W. (2009). High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect 11, 946-955.
35. Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. (2010). Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11, 785-797.
36. Rocco, F., De Gregorio, E., Colonna, B. & Di Nocera, P. P. (2009). Stenotrophomonas maltophilia genomes: a start-up comparison. Int J Med Microbiol 299, 535-546.
37. Rossier, O., Starkenburg, S. R. & Cianciotto, N. P. (2004). Legionella pneumophila type II protein secretion promotes virulence in the A/J mouse model of Legionnaires' disease pneumonia. Infect Immun 72, 310-321.
38. Ryan, R. P., Monchy, S., Cardinale, M., Taghavi, S., Crossman, L., Avison, M. B., Berg, G., van der Lelie, D. & Dow, J. M. (2009). The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Microbiol 7, 514-525.
39. Safdar, A. & Rolston, K. V. (2007). Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45, 1602-1609.
40. Sa nchez, M. B. and Martinez, J. L. (2010). SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 54, 580-581.
41. Sánchez, M. B., Hernández, A., Rodríguez-Martínez, J. M., Martínez- Martínez, L. & Martínez, J. L. (2008). Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol 8, 148.
42. Sánchez, M. B., Hernandez, A. & Martinez, J. L. (2009). Stenotrophomonas maltophilia drug resistance. Future Microbiol 4, 655-660.
43. Schaumann, R., Laurin, F. & Rodloff, A. C. (2008). Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprinting. Int J Hyg Environ Health 211, 292-298.
44. Shimizu, K., Kikuchi, K., Sasaki, T., Takahashi, N., Ohtsuka, M., Ono, Y. & Hiramatsu, K. (2008). Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 52, 3823-3825.
45. Spicuzza, L., Sciuto, C., Vitaliti, G., Di Dio, G., Leonardi, S. & La Rosa, M. (2009). Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur J Clin Microbiol Infect Dis 28, 191-195.
46. Travassos, L. H., Pinheiro, M. N., Coelho, F. S., Sampaio, J. L., Merquior, V. L. & Marques, E. A. (2004). Phenotypic properties, drug susceptibility and genetic relatedness of Stenotrophomonas maltophilia clinical strains from seven hospitals in Rio de Janeiro, Brazil. J Appl Microbiol 96, 1143-1150.
47. Valdezate, S., Vindel, A., Martín-Dávila, P., Del Saz, B. S., Baquero, F. & Cantón, R. (2004). High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 42, 693-699.
48. Waters, V. J., Gómez, M. I., Soong, G., Amin, S., Ernst, R. K. & Prince, A. (2007). Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Infect Immun 75, 1698-1703.
49. Waters, V., Yau, Y., Prasad, S., Lu, A., Atenafu, E., Crandall, I., Tom, S., Tullis, E. & Ratjen, F. (2011). Stenotrophomonas maltophilia in cystic fibrosis: Serologic response and effect on lung disease. Am J Respir Crit Care Med 183, 635-640.
50. Wilson, K. R., Napper, J. M., Denvir, J., Sollars, V. E. & Yu, H. D. (2007). Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages. Microbiology 153, 968-979.
51. Yi, H., Srinivasan, S. & Kim, M. K. (2010). Stenotrophomonas panacihumi sp. nov., isolated from soil of a ginseng field. J Microbiol 48, 30-35.
52. Zamboni, D. S., Kobayashi, K. S., Kohlsdorf, T., Ogura, Y., Long, E. M., Vance, R. E., Kuida, K., Mariathasan, S., Dixit, V. M. & other authors (2006). The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol 7, 318-325.
53. Zgair, A. K. & Chhibber, S. (2010a). Immunological and pathological aspects of respiratory tract infection with Stenotrophomonas maltophilia in BALB/c mice. J Microbiol Biotechnol 20, 1585-1591.
54. Zgair, A. K. & Chhibber, S. (2010b). Stenotrophomonas maltophilia flagellin induces a compartmentalized innate immune response in mouse lung. J Med Microbiol 59, 913-919.